KHC Shorts Ease Ahead of November 12 Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Kraft Heinz heads into its November 12 earnings release with a short book that has started to unwind, even as options traders grow more cautious and the analyst community continues to trim its targets.
Short interest has pulled back from the year-high flagged in this week's earlier note. It stood at roughly 95.1 million shares as of November 3, down about 1.6% from the peak of 96.8 million reached on October 29. That still leaves short interest at 8.0% of free float, the highest level in at least a year, but the direction has shifted. The lending market itself remains entirely relaxed. Availability has actually risen sharply over the week, up 32% to 596%, meaning there are roughly six shares available to borrow for every one currently lent out. The cost to borrow has dropped to 0.33%, down 37% on the week, its lowest reading in the 30-day window. The short book is large but under no pressure whatsoever: bears can add or exit freely.
Options are telling a more defensive story. The put/call ratio has climbed to 0.62, well above its 20-day mean of 0.55 and running roughly 1.6 standard deviations above that average. That is not an extreme reading, but it is the most guarded options positioning seen on this stock in several weeks, and it sits notably higher than where the ratio has spent most of October. The 52-week high remains 0.91, so there is room to go, but the direction heading into the print is clear.
The Street has been in a steady downward revision cycle. JP Morgan lowered its target to $23 from $24 in mid-October, keeping an Underweight rating. Barclays and Wells Fargo also cut targets, to $25 and $23 respectively, both staying at Equal-Weight. The mean price target is $24.69, fractionally above where the stock closed on November 3 at $24.52, leaving almost no implied upside from consensus. The outlier is RBC Capital, which initiated in September with an Outperform and a $32 target, a view anchored on the Heinz and Philadelphia brands and what the bulls describe as a structurally improving free cash flow story, with $1.7 billion generated in the first half of 2026 and roughly 1.8 times coverage of the annual dividend. Against that sits the bear case: US retail volume down 5.4%, market share slipping, and a 27.5% Berkshire Hathaway stake that may cap re-rating potential until that overhang resolves. The ORTEX short score has eased slightly to 57.1 from above 59 earlier in the week, while the earnings yield factor ranks in the 79th percentile, the strongest single score in the factor profile.
Berkshire's near-unchanged stake of 325.6 million shares, 27.5% of the company, remains the dominant ownership story. BlackRock added just over one million shares in the September quarter to reach 6.4% of shares, while the Vanguard complex in aggregate holds above 8%. One item that remains on the register, though filed in April and now six months stale: a Schedule 13D activist filing by an entity called Link Co at 10% of the class. ORTEX's disclosure note applies in full here: 13D positions are event-driven disclosures around the 5% threshold, and the stake is as last disclosed. No subsequent amendments have appeared in the data.
The single most consequential data point to monitor is what the company reports on November 12 around US retail volume trends and whether the $700 million reinvestment program is producing any measurable share recovery in the core categories.
Stocks in this article
See the live data behind this article on ORTEX.
Open KHC on ORTEX →How this article was generated
- Generated
- 4 Nov 2026, 20:09
- Data as of
- 4 Nov 2026, 20:08
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.